Log in or Sign up for Free to view tailored content for your specialty!
Stomach/Duodenum News
Ambu receives 510(k) clearance for single-use endoscope for GI conditions
Ambu Inc. announced it received FDA 510(k) clearance for the Ambu aScope Duodeno.
Growth stunting in children with EED linked with duodenal microbiota, enteropathy
Investigators observed a relationship between growth stunting and small intestinal microbiota components and enteropathy in children with environmental enteric dysfunction.
Log in or Sign up for Free to view tailored content for your specialty!
Tradipitant improves nausea, vomiting in gastroparesis
Tradipitant correlated with statistically and clinically meaningful improvements in nausea and decreased vomiting in patients with idiopathic or diabetic gastroparesis, according to results from Gastroenterology.
ASMBS: Bariatric surgery ‘medically necessary’ during COVID-19 pandemic
Bariatric surgery can improve obesity and the related diseases that increase risks for worse COVID-19 outcomes and should not be considered an elective procedure, according to the American Society for Metabolic and Bariatric Surgery.
FDA approves Gimoti for diabetic gastroparesis
Evoke Pharma announced in a press release that the FDA has approved the new drug application for Gimoti nasal spray to relieve symptoms in adults with acute and recurrent diabetic gastroparesis.
Aspirin doubles risk for upper GI bleeding events in older adults
Aspirin almost doubles the risk for serious upper gastrointestinal bleeding in older people and can further increase with age, smoking, chronic kidney disease and NSAIDs, according to data from Digestive Disease Week.
Lower BMI, greater weight loss before bariatric surgery decrease risk for 30-day mortality
Among nearly half a million adults from the United States and Canada who underwent weight-loss surgery, those with lower presurgical BMI and those who lost even a small amount of weight before the procedure were less likely to die within 30 days, according to findings published in JAMA Network Open.
FDA warns of overinflation, acute pancreatitis with certain intragastric balloons for weight loss
The FDA on Monday issued a Letter to Health Care Providers detailing risks for hyperinflation and acute pancreatitis observed in post-approval studies for two liquid-filled intragastric balloons indicated for weight loss, both approved in 2015 and manufactured by Apollo Endosurgery.
Delayed removal of swallowed button batteries in kids may further damage the stomach
Children who swallow button batteries are more likely to experience gastric damage if the object is removed 12 or more hours after ingestion, according to research published in Gastrointestinal Endoscopy.
Greater preconscious attention to food in severe obesity may explain weight regain after bariatric surgery
Among a cohort of adults who underwent weight-loss surgery, those with severe obesity before surgery showed a greater preconscious attentional bias response to food stimuli compared with adults whose obesity was less extreme, suggesting that a subconscious response to food may drive weight regain among some adults, according to findings accepted for presentation at the Endocrine Society Annual Meeting.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read